Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar adenocarcinoma
- PMID: 21383610
- PMCID: PMC4425125
- DOI: 10.1097/PAS.0b013e31820eb25b
Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar adenocarcinoma
Abstract
It is unknown whether ductal adenocarcinomas are more aggressive when matched for Gleason score (assigning the ductal component as Gleason pattern 4). Moreover, little is known whether a certain percentage of the ductal component is needed to account for its more aggressive behavior. Of 18,552 radical prostatectomies performed from 1995 to 2008, 93 cases with a ductal adenocarcinoma component were identified. Cases were classified based on their ductal/acinar ratio (<10%; ≥10% and <50%; ≥50%). There was no difference in the distribution of Gleason score 3+4=7 versus 4+3=7 between ductal and nonductal tumors, such that cases were combined as Gleason score 7. There was no age, race, and serum prostate-specific antigen difference between patients with and without ductal adenocarcinoma. Cases with ductal adenocarcinoma were less likely to be organ confined (36.6% vs 65.6%) and more likely to show seminal vesicle invasion (SVI) (19.3% vs 5.3%), P<0.0001. There was no difference in lymph node metastases or positive margins between cases with and without ductal features. An increasing percentage of the ductal component correlated with an increased risk of extraprostatic extension (P=0.04) and SVI (P<0.0001). To account for overall different Gleason scores between ductal and nonductal cases, and the effect of differing percentages of ductal features as well, the following analysis was carried out. For Gleason score 7 cases and ≥10% ductal differentiation, cases with ductal features were more likely to have nonfocal extraprostatic extension (64.0%) versus cases without ductal features (34.7%), P=0.002. In this group, there was no statistically significant difference in SVI or lymph node involvement between Gleason score 7 ductal and nonductal tumors. For Gleason score 7 cases with <10% ductal features, there was no difference in pathologic stage versus nonductal cases. There was no difference in pathologic stage between ductal and nonductal cases for Gleason score 8 to 10 cases, regardless of the percentage of the ductal component. This study shows that ductal adenocarcinoma admixed with Gleason pattern 3 is more aggressive than Gleason score 7 acinar cancer, as long as the ductal component is ≥10%. In cases with a very minor ductal component, these differences are lost. In addition, Gleason score 8 to 10 tumors with ductal features are not significantly more aggressive that acinar Gleason score 8 to 10 cancers in which the pure high-grade tumor, regardless of ductal features, determines the behavior.
Figures
Similar articles
-
Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type.Ann Diagn Pathol. 2019 Apr;39:59-62. doi: 10.1016/j.anndiagpath.2019.02.007. Epub 2019 Feb 10. Ann Diagn Pathol. 2019. PMID: 30772651
-
Prostatic Ductal Adenocarcinoma Controlled for Tumor Grade, Stage, and Margin Status Does Not Independently Influence the Likelihood of Biochemical Recurrence in Localized Prostate Cancer After Radical Prostatectomy.Arch Pathol Lab Med. 2022 Aug 1;146(8):1012-1017. doi: 10.5858/arpa.2021-0048-OA. Arch Pathol Lab Med. 2022. PMID: 34739539
-
Incidence of Extraprostatic Extension at Radical Prostatectomy with Pure Gleason Score 3 + 3 = 6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed "Not Cancer" and for Selection Criteria for Active Surveillance.J Urol. 2018 Jun;199(6):1482-1487. doi: 10.1016/j.juro.2017.11.067. Epub 2017 Nov 15. J Urol. 2018. PMID: 29154905
-
Variants of acinar adenocarcinoma of the prostate mimicking benign conditions.Mod Pathol. 2018 Jan;31(S1):S64-70. doi: 10.1038/modpathol.2017.137. Mod Pathol. 2018. PMID: 29297496 Review.
-
Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients.Pathology. 2024 Feb;56(1):33-38. doi: 10.1016/j.pathol.2023.10.005. Epub 2023 Nov 23. Pathology. 2024. PMID: 38071161 Review.
Cited by
-
Prostatic ductal adenocarcinoma: An aggressive variant that is underdiagnosed and undersampled on transrectal ultrasound (TRUS)-guided needle biopsy.Can Urol Assoc J. 2015 Sep-Oct;9(9-10):302-6. doi: 10.5489/cuaj.2976. Can Urol Assoc J. 2015. PMID: 26664660 Free PMC article.
-
Comparing the outcomes of ductal versus acinar adenocarcinoma in patients undergoing robotic-assisted radical prostatectomy: propensity-matched analysis of a prostate cancer referral center.Int Urol Nephrol. 2025 Jun 25. doi: 10.1007/s11255-025-04619-7. Online ahead of print. Int Urol Nephrol. 2025. PMID: 40560522
-
False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillance.Insights Imaging. 2015 Aug;6(4):449-63. doi: 10.1007/s13244-015-0411-3. Epub 2015 May 23. Insights Imaging. 2015. PMID: 26002487 Free PMC article.
-
ECR 2015 Book of Abstracts - D - Satellite Symposia.Insights Imaging. 2015 Mar;6(Suppl 1):449-57. doi: 10.1007/s13244-015-0389-x. Insights Imaging. 2015. PMID: 25708996 Free PMC article. No abstract available.
-
Intraductal Carcinoma of the Prostate Gland: Recent Advances.Yonsei Med J. 2016 Sep;57(5):1054-62. doi: 10.3349/ymj.2016.57.5.1054. Yonsei Med J. 2016. PMID: 27401634 Free PMC article. Review.
References
-
- Aydin H, Zhang J, Samaratunga H, et al. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management. BJU Int. 2010;105:476–480. - PubMed
-
- Bock BJ, Bostwick DG. Does prostatic ductal adenocarcinoma exist? Am J Surg Pathol. 1999;23:781–785. - PubMed
-
- Bostwick DG, Kindrachuk RW, Rouse RV. Prostatic adenocarcinoma with endometrioid features: clinical, pathologic, and ultra-structural findings. Am J Surg Pathol. 1985;9:595–609. - PubMed
-
- Brinker DA, Potter SR, Epstein JI. Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol. 1999;23:1471–1479. - PubMed
-
- Christensen WN, Steinberg G, Walsh PC, et al. Prostatic duct adenocarcinoma: findings at radical prostatectomy. Cancer. 1991;67:2118–2124. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical